Corteva, Inc. (CTVA), a company involved in the agriculture business, gained an increase of 1.88% during Thursday’s regular trading session and closed the day at %58.49. In the aftermarket trading session, CTVA stock has nominally increased by 0.017% to close the day at $58.50. The increase could be attributed to an agreement with Marrone Bio Innovations.
Marrone Bio Agreement with CTVA
On Thursday, Marrone Bio Innovations, Inc., a growth-oriented agricultural company, announced to have signed an agreement with Corteva Agriscience (CTVA). The agreement was concerned with the expansion for MBI technologies to have an opportunity for usage on the seeds for row crops being sold by Corteva across the globe. Corteva is currently getting seed treatment solutions from Marrone Bio to be used across European Peninsula.
Implementation of Global Business Organization Model
On 21st March, Corteva Agrisciences (CTVA) announced the implementation of the global business-unit organization model. The company would do so to provide support to its operating performance metrics in the longer term. To act upon the plan, Robert King would be inducted into the role of Executive Vice President of Crop Protection Business Unit, while Tim Glenn would be sworn in as Executive Vice President of Seed Business Unit.
Unveiling Vorceed™ Enlist
On the 10th of March, Corteva Agrisciences (CTVA) unveiled Vorceed™ Enlist®, the company’s next-generation corn rootworm trait technology. Vorceed would enable the farmers to properly manage corn rootworm acres via utilizing more options than any of the other seed corn products used. The company said that it was in the final stages to commercially launch the Vorceed Enlist products in US and Canada.
What’s Ahead for CTVA?
Looking ahead, analysts are of the view that CTVA stock should be considered a hold candidate. The stock holds several positive technical signals at the moment, but they are not enough for it to be considered a buy candidate. Therefore, investors should take a careful decision regarding investment in CTVA stock.